39 studies found for: Open Studies | "Hypoglycemic Agents"
† Study has passed its completion date and status has not been verified in more than two years.
|1||Not yet recruiting||
Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy
Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
The Effects of add-on Anti-diabetic Drugs in Type 2 Diabetic Patients
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
|7||Not yet recruiting||
Effect of Anti-diabetic Drugs on Glycemic Variability
Glycemic Emergency Management (GEM); An App for Rapid Response to Hypoglycemic and Hyperglycemic Situations
Acute Kidney Injury in Patients on Dapagliflozin and Other Antidiabetic Medications
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Changes in Arterial Stiffness and Endothelial Glycocalyx in Patients With Poorly Controlled Diabetes Mellitus Type 1 or Type 2 After Optimization of Antidiabetic Medication.
Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea
Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy
Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs
A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification
A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
|17||Not yet recruiting||
Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2
A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients
The Practical Evidence of Antidiabetic Combination Therapy in Korea
Comparison Between Hypoglycemic Counter Regulatory Responses in Type 1 Diabetics vs Control Subjects